characteristics.text: SAMN20253988
characteristics.characteristic: External Id
characteristics.text: Department of Chemistry and Chemical Biology, Harvard University
characteristics.characteristic: INSDC center name
characteristics.text: 2022-06-17T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-06-17T02:06:27.850Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS9518046
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS9518046
characteristics.characteristic: SRA accession
characteristics.text: Flag-NLS-M.CviPI-Lamin-B1 K562 clonal cells
characteristics.characteristic: cell line
characteristics.text: chronic myeloid leukemia
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Flag-NLS-M.CviPI-Lamin-B1 K562 clonal cells, EZH2i 72 hours, Doxycycline 24 hours
characteristics.characteristic: source_name
characteristics.text: K562_GSK343_RNAseq_rep2
characteristics.characteristic: title
characteristics.text: GSK343 (1µM) for 72 hours and induced with doxcycline (1µg/mL) for the final 24 hours of treatment
characteristics.characteristic: treatment